JP2002029991A - Arginase activity accelerator and preparation for external use for skin containing the same - Google Patents

Arginase activity accelerator and preparation for external use for skin containing the same

Info

Publication number
JP2002029991A
JP2002029991A JP2000218130A JP2000218130A JP2002029991A JP 2002029991 A JP2002029991 A JP 2002029991A JP 2000218130 A JP2000218130 A JP 2000218130A JP 2000218130 A JP2000218130 A JP 2000218130A JP 2002029991 A JP2002029991 A JP 2002029991A
Authority
JP
Japan
Prior art keywords
skin
weight
extract
arginase activity
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000218130A
Other languages
Japanese (ja)
Other versions
JP5382969B2 (en
Inventor
Misaki Ishida
実咲 石田
Saori Satou
さおり 佐藤
Ron Hashizume
論 橋爪
Shinji Hayashi
伸二 林
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NOF Corp
Original Assignee
NOF Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NOF Corp filed Critical NOF Corp
Priority to JP2000218130A priority Critical patent/JP5382969B2/en
Publication of JP2002029991A publication Critical patent/JP2002029991A/en
Application granted granted Critical
Publication of JP5382969B2 publication Critical patent/JP5382969B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Abstract

PROBLEM TO BE SOLVED: To provide an arginase activity accelerator capable of controlling the arginase activity in the skin and continuously imparting humectant effect to the skin even with a small amount, and excellent in safety, and to provide a preparation for external use for the skin containing the arginase activity accelerator and excellent in the durability of the humectant effect, the improving effect on the improvement of rough skin and safety. SOLUTION: An arginase activity accelerator containing an extract of GOSYUYU (fruit of Evodia rutaecarpa) as an active ingredient.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明はアルギナーゼ活性促
進剤およびそれを含有する皮膚外用剤に関し、更に詳し
くは、保湿作用を発揮させる効果に優れ、しかも安全性
に優れたアルギナーゼ活性促進剤およびそれを含有する
化粧料、医薬品等の皮膚外用剤に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to an arginase activity promoter and an external preparation for skin containing the same, and more particularly, to an arginase activity promoter excellent in the effect of exhibiting a moisturizing effect and excellent in safety, and the same. The present invention relates to an external preparation for skin such as cosmetics and medicines contained therein.

【0002】[0002]

【従来の技術】通常、人の皮膚表面は皮脂膜に覆われて
いて水分の蒸散が適度に抑制されている。そして、皮膚
の水分を適切な範囲に保つことは皮膚の健康の面から見
て非常に大切なことであり、水分が不足すると肌荒れ等
を生じやすくなる。そこで、化粧料、医薬品等のいわゆ
る外皮に適応される「皮膚外用剤」においては肌荒れ防
止や肌荒れの改善の為にグリセリン、1,3−ブチレン
グリコール、ソルビトール等の多価アルコール、ピロリ
ドンカルボン酸塩、ヒアルロン酸等の酸性ムコ多糖類、
キチン、キトサンおよびそれらの誘導体、蛋白加水分解
物、植物抽出物、尿素等の保湿成分の配合が行われてき
た。しかしながらこれらの保湿成分を用いた手法は皮膚
表面においてその物質の物理化学的な保湿の性質を利用
しているだけであり、その物質の皮膚細胞におよぼす生
理的な機能に基づくものではない。また、多く配合する
と不快なべたつきを有することとなり感触が好まれない
ことがある。さらに、これらの保湿成分は皮膚より除去
されると効果は消失するため、その効果は一過性である
と言わざるを得ない。そのため、皮膚細胞に働きかけ保
湿成分の産生を促す薬剤の開発が望まれていた。アルギ
ナーゼはアルギニンをオルニチンと尿素に加水分解する
尿素サイクル中の酵素であり、脊椎動物の肝臓、腎臓な
どをはじめ生物界に広く分布している。ヒト皮膚におい
てもその存在は古くから知られており、表皮細胞の増殖
に関連したポリアミン生合成やプロリン生合成のための
オルニチン供給酵素として知られている。
2. Description of the Related Art Normally, the surface of human skin is covered with a sebum film, and the evaporation of water is appropriately suppressed. It is very important to keep skin moisture in an appropriate range from the viewpoint of skin health, and lack of moisture easily causes skin roughness and the like. Therefore, in "skin external preparations" adapted to the so-called outer skin of cosmetics and pharmaceuticals, polyhydric alcohols such as glycerin, 1,3-butylene glycol and sorbitol, and pyrrolidone carboxylate are used to prevent rough skin and improve rough skin. , Acidic mucopolysaccharides such as hyaluronic acid,
Mixing of moisturizing components such as chitin, chitosan and their derivatives, protein hydrolysates, plant extracts, and urea has been performed. However, the methods using these moisturizing components only utilize the physicochemical moisturizing properties of the substance on the skin surface, and are not based on the physiological function of the substance on skin cells. In addition, when a large amount is blended, it may have unpleasant stickiness and the feeling may not be preferred. Furthermore, the effect of these moisturizing components disappears when removed from the skin, so the effect must be said to be transient. Therefore, the development of a drug that works on skin cells to promote the production of moisturizing components has been desired. Arginase is an enzyme in the urea cycle that hydrolyzes arginine to ornithine and urea, and is widely distributed in the living world, including vertebrate liver and kidney. Its existence in human skin has been known for a long time, and is known as an ornithine-supplying enzyme for polyamine biosynthesis and proline biosynthesis related to epidermal cell proliferation.

【0003】特開平10−7581号公報においてはこ
のアルギナーゼの皮膚中での生理機能を皮膚の天然保湿
因子(NMF)成分である“尿素”の産生に関連づけて
おり、特定の生薬エキスとして“木通”の抽出エキスが
皮膚中のアルギナーゼ活性を調節して皮膚に継続的に保
湿効果を与えることが報告されている。“尿素”は高い
保湿能を有するだけでなく、角質溶解剥離作用や角質柔
軟化作用を有する皮膚にとって重要な成分であり、昔か
ら化粧料、医薬品等の皮膚外用剤に多く配合されている
成分である。しかし、水と反応して分解し易く、分解す
るとアンモニアと炭酸ガスを生じることから、臭気や安
全性に問題を生じ易かった。さらに、尿素を配合した皮
膚外用剤は特有の刺激感を有する為、使用部位が限定さ
れるという欠点を有していた。一方、このアルギナーゼ
活性促進剤を使用すると“尿素”の皮膚内生成を高める
ことにより、これらの問題を解決しながら“尿素”自体
の有効性を発揮することが可能であり、さらにはその効
果の持続性が期待できることから、非常に有用な手段と
考えられる。そのため、より少量でより高い効果を発揮
でき、しかも安全性および安定性に優れた高いアルギナ
ーゼ活性促進剤の開発が望まれていた。
In Japanese Patent Application Laid-Open No. 10-7581, the physiological function of arginase in the skin is related to the production of "urea" which is a natural moisturizing factor (NMF) component of the skin. It has been reported that Tong's extracted extract modulates arginase activity in the skin to provide a continuous moisturizing effect on the skin. "Urea" is an important component for skin that not only has a high moisturizing ability but also has a keratolytic and exfoliating action and a keratin softening action, and is an ingredient that has long been used in skin and external preparations such as cosmetics and pharmaceuticals. It is. However, it is easily decomposed by reacting with water, and when decomposed, produces ammonia and carbon dioxide gas, so that it is easy to cause problems in odor and safety. Further, since the skin external preparation containing urea has a specific irritating feeling, it has a drawback that its use site is limited. On the other hand, when this arginase activity promoter is used, it is possible to exhibit the effectiveness of "urea" itself while solving these problems by increasing the production of "urea" in the skin. It is considered to be a very useful tool because of its sustainability. Therefore, there has been a demand for the development of a high arginase activity promoter which can exert a higher effect with a smaller amount and which is excellent in safety and stability.

【0004】[0004]

【発明が解決しようとする課題】本発明は上記課題を解
決し、少量でも皮膚中のアルギナーゼ活性を調節して皮
膚に継続的に保湿効果を与えることができ、しかも安全
性に優れたアルギナーゼ活性促進剤およびそれを含有す
る保湿効果の持続性、肌荒れ改善効果、安定性に優れた
皮膚外用剤を提供することを目的とする。
DISCLOSURE OF THE INVENTION The present invention solves the above-mentioned problems, and can regulate the arginase activity in the skin even in a small amount to give a continuous moisturizing effect to the skin, and is excellent in safety. An object of the present invention is to provide an accelerator and a skin external preparation containing the same, which has excellent moisturizing effect, skin roughness improving effect, and stability.

【0005】[0005]

【課題を解決するための手段】すなわち本発明は、
(1)a.呉茱萸(ゴシュユ)の抽出エキスを有効成分
として含有するアルギナーゼ活性促進剤、(2)a.
(1)記載のアルギナーゼ活性促進剤を乾燥残留物とし
て0.0001〜5重量%、b.炭素数6〜22のカル
ボン酸またはその誘導体を0.01〜50重量%含有す
ることを特徴とする皮膚外用剤、(3)b.炭素数6〜
22のカルボン酸またはその誘導体としてcis−9−
オクタデセン酸が80重量%以上でありかつcis−9
−不飽和脂肪酸が85重量%以上である脂肪酸またはそ
の誘導体を含有する(2)記載の皮膚外用剤である。
That is, the present invention provides:
(1) a. Arginase activity promoter containing an extract of Goshuyu as an active ingredient, (2) a.
0.001 to 5% by weight of the arginase activity promoter described in (1) as a dry residue, b. An external preparation for skin, comprising 0.01 to 50% by weight of a carboxylic acid having 6 to 22 carbon atoms or a derivative thereof, (3) b. Carbon number 6 ~
Cis-9- as a carboxylic acid or a derivative thereof 22
Octadecenoic acid is 80% by weight or more and cis-9
-The external preparation for skin according to (2), which contains a fatty acid having an unsaturated fatty acid content of 85% by weight or more or a derivative thereof.

【0006】[0006]

【発明の実施の形態】本発明で用いられる呉茱萸(ゴシ
ュユ)の抽出エキスとは、ミカン科の植物「呉茱萸(ゴ
シュユ)」学名:Evodia rutaecarpa
または「ホンゴシュユ」学名:Evodia offi
cinalisの未熟果をそのままあるいは乾燥した後
に各種溶媒で抽出したエキスである。なお、この呉茱萸
にはエボジアミン、デヒドロボジアミン、イソエボジア
ミン、リタエカルピンなどのアルカロイドやオシメン、
エボデンなどの精油などが含まれており、漢方では健
胃、利尿薬、水毒による頭痛、嘔吐、胸満等に適用され
ている(日本薬草全書 新日本法規出版)。呉茱萸エキ
スの抽出方法としては、炭化水素、エステル、ケトン、
エーテル、ハロゲン化炭化水素、アルコールおよび水か
ら選ばれる1種または2種以上の溶媒と共に加熱還流あ
るいは浸漬して抽出するが、好ましくは水またはエタノ
ール、プロピレングリコール、イソプロピルアルコー
ル、1,3−ブチレングリコールの1種または2種以上
の溶媒で抽出したものであり、更に好ましくは水で抽出
したものである。なお、本発明の呉茱萸の抽出エキスと
は抽出溶液そのもの、もしくはその濃縮物をいう。
BEST MODE FOR CARRYING OUT THE INVENTION The extract of Goshuyu used in the present invention is a plant of the family Rutaceae "Goshuyu" Scientific name: Evodia rutaecarpa
Or "Hongoshuyu" Scientific name: Evodia offi
It is an extract obtained by extracting the immature fruit of C. cinalis as it is or after drying it with various solvents. In addition, this goshuyu contains alkaloids such as evodiamine, dehydrobodiamine, isoevodiamine, and ritaecarpine, ocimene,
It contains essential oils such as Eboden, and is used in Chinese medicine for stomach stomach, diuretics, headache due to water poisoning, vomiting, chest stomach, etc. As a method for extracting Goshuyu extract, hydrocarbons, esters, ketones,
Extraction is performed by heating under reflux or immersion together with one or more solvents selected from ethers, halogenated hydrocarbons, alcohols and water, preferably water or ethanol, propylene glycol, isopropyl alcohol, 1,3-butylene glycol. And extracted with one or more solvents, and more preferably extracted with water. In addition, the extract of goshuyu of the present invention refers to an extract solution itself or a concentrate thereof.

【0007】本発明の皮膚外用剤においてa.成分であ
る呉茱萸の抽出エキスの配合量は、組成物全量中に乾燥
残留物として0.0001〜5重量%であることが好ま
しく、0.0005〜3重量%であることが更に好まし
い。0.0001重量%未満では保湿効果や肌荒れ改善
効果および臭気安定性改善効果が発揮され難く、5重量
%を超えると経時安定性に問題を生じたり、コスト的に
不利になる。本発明でいう乾燥残留物とは通常抽出エキ
スを105℃で乾燥するかまたは減圧乾固して溶媒を除
去した時の残留物である溶質を指すが、抽出溶媒が不揮
発性の場合にはガスクロマトグラフィー、高速液体クロ
マトグラフィー等により溶媒量を定量した値から溶質量
を計算値として求め、乾燥残留物量と見なす。
In the external preparation for skin of the present invention, a. The amount of the extract of goshuyu, which is a component, is preferably 0.0001 to 5% by weight, more preferably 0.0005 to 3% by weight, as a dry residue in the total amount of the composition. If it is less than 0.0001% by weight, the moisturizing effect, the effect of improving skin roughness and the effect of improving odor stability are hardly exhibited, and if it exceeds 5% by weight, there is a problem in stability over time and the cost is disadvantageous. The dry residue referred to in the present invention generally refers to a solute that is a residue obtained by drying the extract at 105 ° C. or drying under reduced pressure to remove the solvent. The dissolved mass is determined as a calculated value from the value obtained by quantifying the amount of the solvent by chromatography, high performance liquid chromatography, and the like, and is regarded as the amount of the dried residue.

【0008】b.成分である炭素数6〜22のカルボン
酸またはその誘導体において、炭素数6〜22のカルボ
ン酸は、炭素数6〜22の直鎖または分岐の1価または
多価カルボン酸であり、例えば、ヘキサン酸、オクタン
酸、1,8−オクタンジカルボン酸、デカン酸、ドデカ
ン酸、テトラデカン酸、cis−9−オクタデセン酸、
cis−9,cis−12−オクタデカジエン酸、エイ
コサン酸、ドコサン酸等が挙げられ、その誘導体として
は、1価または多価アルコールとのエステル、アンモニ
アや有機アミンとの脱水縮合物であるアミド等がある。
さらに、これらカルボン酸を還元して得られるアルコー
ルおよびそのアルコールと1価または多価アルコールと
のエーテルや無機酸、有機酸とのエステル等が挙げられ
る。ただし、本発明においてはb.成分は上記成分の中
で特に親油性の成分であり、具体的にはHLBが8以下
の非イオン性界面活性剤または油性成分である。b.成
分として好ましいものは、炭素数6〜22のカルボン酸
またはその誘導体がcis−9−オクタデセン酸80重
量%でありかつcis−9−不飽和脂肪酸85重量%で
ある脂肪酸またはその誘導体であり、更に好ましいもの
はcis−9−オクタデセン酸85重量%でありかつc
is−9−不飽和脂肪酸90重量%である脂肪酸または
その誘導体である。cis−9−不飽和脂肪酸とは脂肪
酸組成の骨格にcis−9−の二重結合を含むものであ
る。脂肪酸組成はガスクロマトグラフィー測定による面
積比により求めることとする。
B. In the carboxylic acid having 6 to 22 carbon atoms as a component or the derivative thereof, the carboxylic acid having 6 to 22 carbon atoms is a linear or branched monovalent or polyvalent carboxylic acid having 6 to 22 carbon atoms, for example, hexane Acid, octanoic acid, 1,8-octanedicarboxylic acid, decanoic acid, dodecanoic acid, tetradecanoic acid, cis-9-octadecenoic acid,
cis-9, cis-12-octadecadienoic acid, eicosanoic acid, docosanoic acid and the like, and derivatives thereof are esters with monohydric or polyhydric alcohols and amides which are dehydration condensates with ammonia or organic amines. Etc.
Further, alcohols obtained by reducing these carboxylic acids, ethers of the alcohols with monohydric or polyhydric alcohols, esters of inorganic acids, organic acids and the like can be mentioned. However, in the present invention, b. The component is a lipophilic component among the above components, specifically, a nonionic surfactant or an oil component having an HLB of 8 or less. b. Preferred as the component is a fatty acid or a derivative thereof in which the carboxylic acid having 6 to 22 carbon atoms or a derivative thereof is cis-9-octadecenoic acid 80% by weight and cis-9-unsaturated fatty acid 85% by weight, and Preferred is 85% by weight of cis-9-octadecenoic acid and c
Fatty acid which is 90% by weight of is-9-unsaturated fatty acid or a derivative thereof. The cis-9-unsaturated fatty acid includes a cis-9-double bond in the skeleton of the fatty acid composition. The fatty acid composition is determined from the area ratio determined by gas chromatography.

【0009】本発明の皮膚外用剤においてb.成分であ
る炭素数6〜22のカルボン酸またはその誘導体の配合
量は組成物全量中に0.01〜50重量%であり、好ま
しくは0.1〜30重量%である。0.01重量%未満
では十分な保湿効果の持続性および肌荒れ防止の改善効
果が得られなく、50重量%を超えると感触が悪くなっ
たり刺激を有することがあり好ましくない。
In the external preparation for skin of the present invention, b. The compounding amount of the carboxylic acid having 6 to 22 carbon atoms or a derivative thereof as a component is 0.01 to 50% by weight, preferably 0.1 to 30% by weight based on the total amount of the composition. If the amount is less than 0.01% by weight, sufficient durability of the moisturizing effect and the effect of preventing rough skin cannot be obtained, and if the amount exceeds 50% by weight, the feeling becomes poor or irritating, which is not preferable.

【0010】本発明のアルギナーゼ活性促進剤は、皮膚
外用剤に配合して好適に使用することができ、化粧料、
医薬品等に使用することができる。
The arginase activity promoter of the present invention can be suitably used by blending it with an external preparation for skin.
It can be used for pharmaceuticals and the like.

【0011】なお、本発明においては、化粧料や医薬品
等の皮膚外用剤に常用されている添加剤を本発明の性能
を損なわない範囲で配合することも可能である。例え
ば、流動パラフィン、流動イソパラフィン、スクワラ
ン、ワセリン、固形パラフィン等の炭化水素系油、牛
脂、豚脂、魚油等の天然油脂、エステル油、ロウ、直鎖
および環状のジメチルポリシロキサン、ポリエーテル変
性ジメチルポリシロキサン、アミノ変性ジメチルポリシ
ロキサン等のシリコーン誘導体、セラミド、コレステロ
ール、蛋白誘導体、ラノリン、ラノリン誘導体、レシチ
ン等の油性基剤、ポリオキシエチレンアルキルエーテ
ル、ポリエチレングリコール脂肪酸エステル、ポリオキ
シプロピレンアルキルエーテル、ポリプロピレングリコ
ール脂肪酸エステル、ソルビタン脂肪酸エステル、ポリ
オキシエチレンソルビタン脂肪酸エステル、ポリオキシ
エチレン硬化ひまし油、ポリグリセリン脂肪酸エステ
ル、ポリオキシエチレングリセリン脂肪酸エステル、ア
ルキルポリグルコシド、ポリオキシエチレンポリオキシ
プロピレンブロックポリマー、アルカノールアミド等の
非イオン性界面活性剤、せっけん、アルキル硫酸エステ
ル塩、アルキルエーテル硫酸エステル塩、α−オレフィ
ンスルホン酸塩、アシルメチルタウリン塩、アシルグル
タミン酸塩、アシルグリシン塩、アシルザルコシン塩、
アシルイセチオン酸塩、アルキルエーテルカルボン酸
塩、アミドエーテル硫酸エステル塩、アルキル燐酸エス
テル塩等の陰イオン性界面活性剤、アルキルジメチルア
ミノ酢酸ベタイン、アミドプロピルジメチルアミノ酢酸
ベタイン、アミドアミノ酸塩、アルキルイミノジ酢酸塩
等の両性界面活性剤、アルキルアミンオキシド、ポリオ
キシエチレンアルキルアミンオキシド等の半極性界面活
性剤、塩化アルキルトリメチルアンモニウム、塩化ジア
ルキルジメチルアンモニウム等の陽イオン性界面活性
剤、アルキルアミン、アミドアミン等の塩酸塩または酢
酸塩、無機顔料、パール顔料、金属粉末顔料、有機顔
料、ジルコニウム等の顔料、クロロフィル、β−カロチ
ン等の天然色素、アルギン酸、カルボキシビニルポリマ
ー、カルボキシメチルセルロース、ヒドロキシプロピル
メチルセルロース、ヒドロキシエチルセルロース、キサ
ンタンガム、ヒアルロン酸等の水溶性高分子、硫酸マグ
ネシウム、塩化ナトリウム、クエン酸ナトリウム、ピロ
リドンカルボン酸ナトリウム等の無機塩または有機塩、
pH調製剤である酸およびアルカリ、殺菌剤、キレート
剤、抗酸化剤、抗炎症剤、紫外線吸収剤、動植物由来の
天然エキス、香料等を配合できる。
In the present invention, additives commonly used in external preparations for skin, such as cosmetics and pharmaceuticals, can be blended as long as the performance of the present invention is not impaired. For example, liquid paraffin, liquid isoparaffin, squalane, petrolatum, hydrocarbon oils such as solid paraffin, natural fats and oils such as tallow, lard, fish oil, ester oil, wax, linear and cyclic dimethylpolysiloxane, polyether-modified dimethyl Silicone derivatives such as polysiloxane and amino-modified dimethylpolysiloxane, ceramides, cholesterol, protein derivatives, lanolin, lanolin derivatives, oily bases such as lecithin, polyoxyethylene alkyl ether, polyethylene glycol fatty acid ester, polyoxypropylene alkyl ether, polypropylene Glycol fatty acid ester, sorbitan fatty acid ester, polyoxyethylene sorbitan fatty acid ester, polyoxyethylene hardened castor oil, polyglycerin fatty acid ester, polyoxyethylene Nonionic surfactants such as glycerin fatty acid ester, alkyl polyglucoside, polyoxyethylene polyoxypropylene block polymer, alkanolamide, soap, alkyl sulfate, alkyl ether sulfate, α-olefin sulfonate, acylmethyl Taurine salt, acyl glutamate, acyl glycine salt, acyl sarcosine salt,
Anionic surfactants such as acyl isethionate, alkyl ether carboxylate, amide ether sulfate, and alkyl phosphate, alkyl dimethyl amino acetate betaine, amido propyl dimethyl amino acetate betaine, amide amino acid salt, alkyl iminodiacetic acid Amphoteric surfactants such as salts; semi-polar surfactants such as alkylamine oxides and polyoxyethylene alkylamine oxides; cationic surfactants such as alkyltrimethylammonium chloride and dialkyldimethylammonium chloride; alkylamines and amidoamines Hydrochloride or acetate, inorganic pigment, pearl pigment, metal powder pigment, organic pigment, pigment such as zirconium, natural pigment such as chlorophyll, β-carotene, alginic acid, carboxyvinyl polymer, carboxymethyl Loin, hydroxypropylmethyl cellulose, hydroxyethyl cellulose, xanthan gum, water-soluble polymers, magnesium sulfate or the like hyaluronic acid, sodium chloride, sodium citrate, inorganic or organic salts such as sodium pyrrolidone carboxylic acid,
Acids and alkalis as pH adjusters, bactericides, chelating agents, antioxidants, anti-inflammatory agents, ultraviolet absorbers, natural extracts derived from animals and plants, fragrances and the like can be added.

【0012】[0012]

【実施例】次に実施例によって本発明を更に詳細に説明
する。 (呉茱萸抽出エキスの調製) 1.水抽出エキス 乾燥後粉砕した30gの呉茱萸に300mlの水を加え
70℃で3時間加熱し、その後、濾過により抽出液から
不溶物を除去し、得られた濾液を減圧乾固して呉茱萸水
抽出エキスを得た。 2.エタノール水溶液による抽出エキス 乾燥後粉砕した30gの呉茱萸に300mlのエタノー
ルを加え、4日放置後濾過した。次に、エタノールで膨
潤した呉茱萸に対して300mlの水を加えて70℃で
3時間加熱し、その後、濾過により抽出液から不要物を
除去し、得られた濾液を減圧乾固して呉茱萸エタノール
水溶液抽出エキスを得た。以下、本法による抽出エキス
を水/EtOH抽出エキスと称する。 (木通抽出エキスの調整) 1.水抽出エキス 乾燥後粉砕した30gの木通に300mlの水を加えて
70℃で3時間加熱し、その後、濾過により抽出液から
不溶液を除去し、得られた濾液を減圧乾固して得られた
木通抽出エキスを得た。
Next, the present invention will be described in more detail by way of examples. (Preparation of Goshuyu extract extract) Water-extracted extract To 30 g of Goshuyu dried and ground, 300 mL of water was added, and the mixture was heated at 70 ° C. for 3 hours. Thereafter, insoluble materials were removed from the extract by filtration, and the obtained filtrate was dried under reduced pressure to obtain Goshuyu. An aqueous extract was obtained. 2. Extract Extract with Ethanol Aqueous Solution To 30 g of Goshuyu dried and ground, 300 ml of ethanol was added, and the mixture was allowed to stand for 4 days and filtered. Next, 300 ml of water was added to the goshuyu swollen with ethanol, and the mixture was heated at 70 ° C. for 3 hours. After that, unnecessary substances were removed from the extract by filtration, and the obtained filtrate was dried under reduced pressure to dryness. An aqueous extract of Goshuyu ethanol was obtained. Hereinafter, the extract extracted by this method is referred to as a water / EtOH extract. (Preparation of Kidori Extract) Water-extracted extract After drying, 300 ml of water was added to 30 g of the pulverized tree and heated at 70 ° C. for 3 hours. Thereafter, the insoluble solution was removed from the extract by filtration, and the obtained filtrate was dried under reduced pressure to obtain a solid. The obtained extract was obtained.

【0013】実施例1:培養細胞によるアルギナーゼ活
性促進効果 マウス表皮細胞(PAM212)を直径10cmの培養
皿内に蒔き、培養皿内が細胞で完全に覆われる程度まで
培養を継続した(培地:ダルベッコ変性イーグル培地+
牛胎児血清10%)。その後、各植物の抽出エキスを培
地(培地:ダルベッコ変性イーグル培地+牛胎児血清1
%)中濃度が抽出エキス乾燥残留物として0〜0.05
重量%となるように添加し、3日間培養した。培養後、
その培地と細胞を回収し、培地中のアルギナーゼの反応
により生じた尿素量と、細胞中のアルギナーゼ活性量を
測定した。各濃度ポイントはすべて5点づつ行った。細
胞中のアルギナーゼ活性量の測定は細胞を1mLの25
mMトリス−塩酸緩衝液(pH=7.5)中でホモジナ
イズしたホモジネートを用いて測定した。ホモジネート
0.05mlを1.5mLの栓付きのマイクロチューブ
に移し取り、0.04mLの0.1M L−アルギニン
溶液を添加し37℃にて3時間インキュベートした。イ
ンキュベート終了後0.01mLの60%過塩素酸を添
加、混和し酵素反応を停止させ10000Gで遠心分離
を行い得られた上清の尿素量を培地中の尿素量と同様の
方法にて測定し、1時間当たり1マイクロモルの尿素を
産生する量をアルギナーゼ1ユニットとした。培地中の
尿素量、細胞内のアルギナーゼ活性とも無添加の場合を
100として5点の平均値を算出した。結果を表1に示
す。
Example 1 Effect of Promoting Arginase Activity by Cultured Cells Mouse epidermal cells (PAM212) were sown in a culture dish having a diameter of 10 cm, and culturing was continued until the culture dish was completely covered with the cells (medium: Dulbecco) Denatured Eagle medium +
Fetal calf serum 10%). Thereafter, the extract of each plant was added to a medium (medium: Dulbecco's modified Eagle medium + fetal calf serum 1).
%) 0-0.05 as the dry residue of the extracted extract
%, And cultured for 3 days. After culture
The medium and cells were collected, and the amount of urea generated by the reaction of arginase in the medium and the amount of arginase activity in the cells were measured. Each concentration point was performed by 5 points. The measurement of the amount of arginase activity in cells was performed by measuring
The measurement was performed using a homogenate homogenized in a mM Tris-HCl buffer (pH = 7.5). 0.05 ml of the homogenate was transferred to a 1.5 mL stoppered microtube, 0.04 mL of a 0.1 M L-arginine solution was added, and the mixture was incubated at 37 ° C. for 3 hours. After the incubation was completed, 0.01 mL of 60% perchloric acid was added and mixed to stop the enzyme reaction, followed by centrifugation at 10,000 G. The amount of urea in the obtained supernatant was measured in the same manner as the amount of urea in the medium. The amount producing 1 micromol of urea per hour was defined as 1 unit of arginase. The urea content in the medium and the intracellular arginase activity were both taken as 100 and the average value of 5 points was calculated. Table 1 shows the results.

【0014】[0014]

【表1】 [Table 1]

【0015】表1より呉茱萸の抽出エキスは培養細胞レ
ベルにおいてアルギナーゼ活性の促進作用に優れてお
り、特に低濃度における効果は木通抽出物より明らかに
優れていた。そして、特に水抽出エキスがその効果が高
かった。
From Table 1, it can be seen that the extract of Goshuyu was excellent in promoting arginase activity at the level of cultured cells, and the effect at low concentrations was clearly superior to the Kindori extract. In particular, the water-extracted extract was highly effective.

【0016】実施例2および比較例1:ヘアレスマウス
塗布試験によるアルギナーゼ活性促進剤の効果 次に動物を使用した試験においても同様の作用を示すか
どうかを調べるために、次のような試験を行った。星野
実験動物より購入した6週齢の雄性ヘアレスマウス(各
群10匹)を用い0.01%の呉茱萸水抽出エキスを含
む50%エタノール溶液200μLを塗布し、その後こ
の塗布を1日2回の頻度で30日間連続して行った。塗
布期間終了後、SKICON−200(IBS社製)を
用いて皮表角層水分含量を測定した後、マウス皮膚を採
取し0.24M塩化アンモニウム(pH=9.4)中に
0℃で30分間浸した後、ピンセットを用いて真皮より
剥離し表皮のみを採取した。採取した表皮を湿重量の1
9倍量の生理緩衝食塩水でホモジナイズした後、遠心分
離を行い、その上清の尿素量とアルギナーゼ活性量を測
定した。尿素量は和光純薬工業株式会社製の尿素窒素−
テストワコーを用い取り扱い説明書通りに使用した。培
地0.02mLと発色試液(発色原液Aと発色原液Bを
5:1で混合したもの)5mLを混和し沸騰水浴中で2
5分間加熱後、流水中で冷却し分光光度計を用い530
nmの吸光度を測定し、別に求めた尿素の検量線より培
地中の尿素量を算出した。アルギナーゼ活性量の測定は
培養細胞のアルギナーゼ活性の測定と同様の方法で行っ
た。同様に0.01%の呉茱萸水/EtOH抽出エキス
を含む50%エタノール溶液の塗布群も試験した。さら
に、抽出エキスを含まない50%エタノールのみの塗布
群と疑似操作だけ群を比較例として用い、疑似塗布群を
100として各群の皮表角層水分含量と表皮ホモジネー
ト中の尿素量とアルギナーゼ活性量をもとめた。結果を
表2に示す。
Example 2 and Comparative Example 1 Effect of Arginase Activity Promoter by Hairless Mouse Application Test Next, the following test was carried out to examine whether or not the same effect is exhibited in a test using animals. Was. Using a 6-week-old male hairless mouse (10 mice per group) purchased from Hoshino experimental animals, 200 μL of a 50% ethanol solution containing 0.01% Goshuyu water extract was applied, and then this application was performed twice a day. For 30 consecutive days. After the application period, after measuring the water content of the skin surface layer using SKICON-200 (manufactured by IBS), mouse skin was collected and placed in 0.24 M ammonium chloride (pH = 9.4) at 0 ° C. for 30 minutes. After soaking for minutes, the skin was separated from the dermis using forceps and only the epidermis was collected. Remove the collected epidermis to the wet weight of 1
After homogenization with 9 times the volume of physiological buffer saline, centrifugation was performed, and the urea content and arginase activity content of the supernatant were measured. The amount of urea is urea nitrogen manufactured by Wako Pure Chemical Industries, Ltd.
It was used according to the instruction manual using Test Wako. Mix 0.02 mL of the medium and 5 mL of the color reagent (a mixture of the color developer A and the color developer B at a ratio of 5: 1) and mix them in a boiling water bath.
After heating for 5 minutes, cool in running water and use a spectrophotometer for 530
The absorbance at nm was measured, and the amount of urea in the medium was calculated from a separately determined urea calibration curve. The measurement of the amount of arginase activity was performed in the same manner as the measurement of arginase activity of the cultured cells. Similarly, a group to which a 50% ethanol solution containing 0.01% Goshuyu water / EtOH extract was applied was also tested. Further, a group of application of only 50% ethanol containing no extract extract and a group of only sham operation were used as comparative examples. I asked for the quantity. Table 2 shows the results.

【0017】[0017]

【表2】 [Table 2]

【0018】表2の結果から明らかなように本発明の呉
茱萸の抽出エキスはヘアレスマウス表皮のアルギナーゼ
活性を上昇させて尿素量を増やし、角層水分量を増大さ
せた。本試験において呉茱萸の抽出エキスを塗布した部
位に、たとえば炎症性の過敏反応の発生、例えば紅斑の
発生等の副作用は全く見られなかった。そのことから呉
茱萸の抽出エキスが副作用を呈さない範囲内で有効にア
ルギナーゼ活性を促進し、尿素量の産生を増大させて角
層水分含量を増大させることが確認された。
As is evident from the results in Table 2, the extract of Goshuyu of the present invention increased the arginase activity in the epidermis of the hairless mouse, increased the amount of urea, and increased the water content of the stratum corneum. In this test, no side effects such as the occurrence of an inflammatory hypersensitivity reaction, for example, the occurrence of erythema, etc. were observed at the site to which the extract of Goshuyu was applied. From these results, it was confirmed that the extract of Goshuyu effectively promotes arginase activity within a range that does not exhibit any side effects, increases the production of urea, and increases the water content of the stratum corneum.

【0019】実施例3〜5および比較例2 表3に示すクリームである皮膚外用剤を調製し、下記の
方法により評価を行った。結果を表3に示す。 (1)保湿効果の持続性 20名の女性(21才〜35才)をパネラーとし、洗顔
した後に皮膚外用剤を使用し、2時間後の肌のうるおい
について下記のように判定し、20名の平均値を求め
て、平均値1.5点以上を保湿効果の持続性の良好な化
粧料であると評価した。 2点:使用直後と変わらず肌が十分うるおっていると感
じた場合。 1点:使用直後と比べてやや肌のうるおいが足りないと
感じた場合。 0点:使用直後と比べて肌のうるおいが足りないと感じ
た場合。 (2)肌荒れ改善効果 肌荒れを生じた10名の女性(25才〜35才)をパネ
ラーとし、皮膚外用剤を一日2回ずつ連続2週間使用し
た時の肌の状態について下記のように判定し、10名の
平均値を求めて、平均値1.5点以上を肌荒れ改善効果
のある化粧料であると評価した。 2点:肌荒れが明らかに治ってきたと感じた場合。 1点:肌荒れがやや治ってきたと感じた場合。 0点:肌荒れ改善効果が全くないと感じた場合。 (3)経時安定性 皮膚外用剤を透明ガラス容器に密封して−5℃、25℃
および40℃で3ヶ月間保存したときの状態を調査し、
下に示す3段階で評価した。 ○:安定性良好(いずれの温度においても外観の変化が
なくブツ等も生じない。) △:安定性やや不良(いずれかの温度において僅かに沈
殿を生じるか僅かに分離が見られる。または僅かにブ
ツ、ダマを生じている。) ×:安定性不良(いずれの温度においても明らかに沈殿
を生じるか分離する。またはブツやダマを生じる。) (4)臭気安定性 皮膚外用剤を透明ガラス容器に密封して−5℃、25℃
および40℃で3ヶ月間保存したときの臭気変化を調査
し、下記に示す3段階で評価を行った。 ○:安定性良好(臭気の変化がほとんどない。) △:安定性やや不良(やや臭気が変化し、若干異臭が発
生している。) ×:安定性不良(明らかに臭気が変化し、異臭が発生し
ている。)
Examples 3 to 5 and Comparative Example 2 Skin external preparations as creams shown in Table 3 were prepared and evaluated by the following methods. Table 3 shows the results. (1) Persistence of moisturizing effect Twenty women (21 to 35 years old) were used as panelists, and after washing their face, using a topical skin preparation, the moisture of the skin after 2 hours was determined as follows, and 20 women were evaluated. The average of 1.5 points or more was evaluated as a cosmetic having good moisturizing effect and good durability. 2 points: When the skin feels sufficiently moist as in immediately after use. 1 point: When feeling that the moisture of the skin is slightly less than immediately after use. 0 point: when the skin feels less moisture than immediately after use. (2) Skin roughening improvement effect Ten women (25 to 35 years old) who had skin roughening were used as panelists, and the skin condition was determined as follows when skin external preparations were used twice a day for two consecutive weeks. The average value of 10 persons was determined, and an average value of 1.5 or more was evaluated as a cosmetic having an effect of improving skin roughness. 2 points: When the user feels that the rough skin has clearly recovered. 1 point: When the user feels that the rough skin has healed a little. 0 point: When it is felt that there is no effect of improving skin roughness. (3) Stability over time A skin external preparation is sealed in a transparent glass container, and stored at -5 ° C and 25 ° C.
And the condition when stored at 40 ° C for 3 months,
The evaluation was performed in three stages shown below. :: good stability (no change in appearance and no blemishes at any temperature) △: somewhat poor stability (slight precipitation or slight separation at any temperature) ×: Poor stability (obviously precipitates or separates at any temperature, or produces dots or lumps.) (4) Odor stability Transparent glass for skin external preparation Seal in a container, -5 ℃, 25 ℃
The change in odor after storage for 3 months at 40 ° C. and 40 ° C. was investigated, and evaluated in the following three grades. :: Good stability (no change in odor) Δ: Slightly poor stability (Slightly changed odor and slightly off-flavor.) ×: Poor stability (Clearly changed odor and off-odor) Has occurred.)

【0020】[0020]

【表3】 [Table 3]

【0021】注1;EXTRA OS−85(日本油脂
(株)製)<脂肪酸組成:cis−9−ヘキサデセン酸
1重量%、cis−9−オクタデセン酸87重量%、c
is−9、cis−12−オクタデセン酸3重量%、ヘ
キサデカン酸3重量%、オクタデカン酸6重量%> 注2;NOFABLE EO−85S(日本油脂(株)
製)<脂肪酸組成:cis−9−ヘキサデセン酸1重量
%、cis−9−オクタデセン酸88重量%、cis−
9、cis−12−オクタデセン酸2重量%、ヘキサデ
カン酸4重量%、オクタデカン酸5重量%> 実施例3〜5より、本発明の皮膚外用剤は肌の保湿効果
の持続性および肌荒れ改善効果に優れるとともに安定性
にも優れていた。比較例2では呉茱萸抽出エキスの代わ
りに木通抽出エキスを配合してことから肌荒れ改善効
果、経時安定性および臭気安定性が悪くなっている。
Note 1: EXTRA OS-85 (manufactured by NOF Corporation) <Fatty acid composition: cis-9-hexadecenoic acid 1% by weight, cis-9-octadecenoic acid 87% by weight, c
is-9, cis-12-octadecenoic acid 3% by weight, hexadecanoic acid 3% by weight, octadecanoic acid 6% by weight> Note 2: NOFABLE EO-85S (NOF Corporation)
Fatty acid composition: cis-9-hexadecenoic acid 1% by weight, cis-9-octadecenoic acid 88% by weight, cis-
9, 2% by weight of cis-12-octadecenoic acid, 4% by weight of hexadecanoic acid, 5% by weight of octadecanoic acid> According to Examples 3 to 5, the external preparation for skin of the present invention has a long-lasting moisturizing effect on the skin and an effect of improving rough skin. Excellent as well as excellent stability. In Comparative Example 2, the effect of improving skin roughness, the stability over time, and the odor stability were deteriorated due to the inclusion of the extract of Kodori instead of the extract of Goshuyu.

【0022】実施例6〜8および比較例3 表4に示す化粧水である皮膚外用剤を調製し、評価
(1)、(2)および(4)は実施例3〜5の方法によ
り、そして(3)経時安定性については下記の方法によ
り評価を行なった。結果を表4に示す。 (3)経時安定性 化粧水を透明ガラス容器に密封して0℃、25℃および
40℃で3ヶ月間保存し、その外観を観察して、下に示
す3段階で評価した。 ○:安定性良好(いずれの温度でも外観の変化がな
い。) △:安定性やや不良(いずれかの温度において若干お
り、沈殿を生じるかまたは若干着色を生じる。) ×:安定性不良(いずれかの温度においてもおり、沈殿
を生じるかまたは分離する。もしくは着色が著しい。)
Examples 6 to 8 and Comparative Example 3 Skin external preparations as lotions shown in Table 4 were prepared, and evaluations (1), (2) and (4) were performed according to the methods of Examples 3 to 5, and (3) The stability over time was evaluated by the following method. Table 4 shows the results. (3) Stability over time The lotion was sealed in a transparent glass container and stored at 0 ° C., 25 ° C. and 40 ° C. for 3 months, and its appearance was observed and evaluated according to the following three grades. :: Good stability (no change in appearance at any temperature) Δ: Slightly poor stability (slightly at any temperature, causing precipitation or slight coloring) ×: Poor stability (any At this temperature, precipitates or separates, or is markedly colored.)

【0023】[0023]

【表4】 [Table 4]

【0024】注1;EXTRA OS−85(日本油脂
(株)製)<脂肪酸組成:cis−9−ヘキサデセン酸
1重量%、cis−9−オクタデセン酸87重量%、c
is−9、cis−12−オクタデセン酸3重量%、ヘ
キサデカン酸3重量%、オクタデカン酸6重量%> 注2;NOFABLE EO−85S(日本油脂(株)
製)<脂肪酸組成:cis−9−ヘキサデセン酸1重量
%、cis−9−オクタデセン酸88重量%、cis−
9、cis−12−オクタデセン酸2重量%、ヘキサデ
カン酸4重量%、オクタデカン酸5重量%> 実施例6〜8より、本発明の皮膚外用剤は肌の保湿効果
の持続性および肌荒れ改善効果に優れるとともに安定性
にも優れていた。比較例3では呉茱萸抽出エキスの代わ
りに木通抽出エキスを配合していることから肌荒れ改善
効果と臭気安定性が悪くなっている。
Note 1: EXTRA OS-85 (manufactured by NOF Corporation) <fatty acid composition: cis-9-hexadecenoic acid 1% by weight, cis-9-octadecenoic acid 87% by weight, c
is-9, cis-12-octadecenoic acid 3% by weight, hexadecanoic acid 3% by weight, octadecanoic acid 6% by weight> Note 2: NOFABLE EO-85S (NOF Corporation)
Fatty acid composition: cis-9-hexadecenoic acid 1% by weight, cis-9-octadecenoic acid 88% by weight, cis-
9, 2% by weight of cis-12-octadecenoic acid, 4% by weight of hexadecanoic acid, 5% by weight of octadecanoic acid> From Examples 6 to 8, the external preparation for skin of the present invention has a long-lasting moisturizing effect and an effect of improving skin roughness. Excellent as well as excellent stability. In Comparative Example 3, the skin roughness improving effect and the odor stability are deteriorated because the extract of Kodori was added instead of the extract of Goshuyu.

【0025】[0025]

【発明の効果】本発明のアルギナーゼ活性促進剤は、少
量でも有効にアルギナーゼ活性を促進し、尿素量の産生
を増大させて角層水分含量を増大させることが確認され
た。また、それを使用した本発明の皮膚外用剤は肌の保
湿効果の持続性および肌荒れ改善効果に優れるとともに
安全性および安定性にも優れている。
It has been confirmed that the arginase activity promoter of the present invention effectively promotes arginase activity even in a small amount, increases the production of urea, and increases the water content of the stratum corneum. In addition, the skin external preparation of the present invention using the same is excellent in persistence of the moisturizing effect on the skin and in improving the roughness of the skin and also in safety and stability.

───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.7 識別記号 FI テーマコート゛(参考) A61P 43/00 107 A61P 43/00 107 111 111 Fターム(参考) 4C083 AA082 AA111 AA112 AA122 AC022 AC072 AC102 AC122 AC172 AC241 AC251 AC252 AC352 AC422 AC442 AC482 AD112 AD152 AD662 CC02 CC04 CC05 DD23 DD27 DD31 EE12 4C088 AB62 AC04 BA08 BA09 BA10 CA03 CA05 CA06 CA07 MA17 MA28 MA63 NA14 ZA89 ZB22 ZC19 ──────────────────────────────────────────────────続 き Continued on the front page (51) Int.Cl. 7 Identification symbol FI Theme coat ゛ (Reference) A61P 43/00 107 A61P 43/00 107 111 111 F F-term (Reference) 4C083 AA082 AA111 AA112 AA122 AC022 AC072 AC102 AC122 AC172 AC241 AC251 AC252 AC352 AC422 AC442 AC482 AD112 AD152 AD662 CC02 CC04 CC05 DD23 DD27 DD31 EE12 4C088 AB62 AC04 BA08 BA09 BA10 CA03 CA05 CA06 CA07 MA17 MA28 MA63 NA14 ZA89 ZB22 ZC19

Claims (3)

【特許請求の範囲】[Claims] 【請求項1】 a.呉茱萸(ゴシュユ)の抽出エキスを
有効成分として含有するアルギナーゼ活性促進剤。
1. A method comprising: a. An arginase activity promoter containing an extract of goshuyu as an active ingredient.
【請求項2】 a.請求項1記載のアルギナーゼ活性促
進剤を乾燥残留物として0.0001〜5重量%、b.
炭素数6〜22のカルボン酸またはその誘導体を0.0
1〜50重量%含有することを特徴とする皮膚外用剤。
2. A method comprising: a. 0.0001 to 5% by weight of the arginase activity promoter according to claim 1 as a dry residue, b.
A carboxylic acid having 6 to 22 carbon atoms or a derivative thereof is 0.0
An external preparation for skin, comprising 1 to 50% by weight.
【請求項3】 b.炭素数6〜22のカルボン酸または
その誘導体としてcis−9−オクタデセン酸80重量
が%以上でありかつcis−9−不飽和脂肪酸85重量
が%以上である脂肪酸またはその誘導体を含有する請求
項2記載の皮膚外用剤。
B. 3. A carboxylic acid having 6 to 22 carbon atoms or a derivative thereof containing a fatty acid or a derivative thereof in which cis-9-octadecenoic acid is 80% by weight or more and cis-9-unsaturated fatty acid is 85% by weight or more. The topical skin preparation according to the above.
JP2000218130A 2000-07-19 2000-07-19 Arginase activity promoter and skin external preparation containing the same Expired - Lifetime JP5382969B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2000218130A JP5382969B2 (en) 2000-07-19 2000-07-19 Arginase activity promoter and skin external preparation containing the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000218130A JP5382969B2 (en) 2000-07-19 2000-07-19 Arginase activity promoter and skin external preparation containing the same

Publications (2)

Publication Number Publication Date
JP2002029991A true JP2002029991A (en) 2002-01-29
JP5382969B2 JP5382969B2 (en) 2014-01-08

Family

ID=18713128

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000218130A Expired - Lifetime JP5382969B2 (en) 2000-07-19 2000-07-19 Arginase activity promoter and skin external preparation containing the same

Country Status (1)

Country Link
JP (1) JP5382969B2 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1454620A3 (en) * 2003-03-06 2005-04-13 Kao Corporation Skin aging-preventing or improving agent
WO2005123735A1 (en) * 2004-06-16 2005-12-29 Kyowa Hakko Kogyo Co., Ltd. Process for producing evodiamine-containing composition
JP2006143608A (en) * 2004-11-16 2006-06-08 Nof Corp Arginase activity promoter and skin care preparation containing the same
WO2010073986A1 (en) * 2008-12-24 2010-07-01 株式会社ファンケル Method for evaluating resistance to skin sunburn by ultraviolet light

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1454620A3 (en) * 2003-03-06 2005-04-13 Kao Corporation Skin aging-preventing or improving agent
WO2005123735A1 (en) * 2004-06-16 2005-12-29 Kyowa Hakko Kogyo Co., Ltd. Process for producing evodiamine-containing composition
JP2006143608A (en) * 2004-11-16 2006-06-08 Nof Corp Arginase activity promoter and skin care preparation containing the same
WO2010073986A1 (en) * 2008-12-24 2010-07-01 株式会社ファンケル Method for evaluating resistance to skin sunburn by ultraviolet light

Also Published As

Publication number Publication date
JP5382969B2 (en) 2014-01-08

Similar Documents

Publication Publication Date Title
WO2010123102A1 (en) Collagen production promoter, anti-photoaging agent, moisture-retention improvement agent, and composite for use on skin
AU2004318989B2 (en) Hair restorer
KR20180138399A (en) Inhibitor for NO activator, Anit-inflammation agent containing of the same, Revitalizing cosmetics containing the same and Manufacturing method thereof
JP2007262012A (en) Hyaluronic acid production promoter, skin external preparation containing the hyaluronic acid production promoter, cosmetic, quasi drug, chapped skin ameliorating agent, and wrinkle ameliorating agent
JPH08283139A (en) Dermal preparation for external use
JPH1179951A (en) Tyrosinase activity promoter
JP2002029991A (en) Arginase activity accelerator and preparation for external use for skin containing the same
JP6052181B2 (en) Cosmetics
JP3507635B2 (en) Composition suitable for external use
JP2001288068A (en) Skin cosmetic
JP2003146886A (en) Filaggrin synthesis accelerator, improver for moisture- retaining function of horny layer, horny layer softener and enhancer of isolated amino acid in horny layer
JPH107581A (en) Arginase activity promoter
JP2003277285A (en) Arginase activity accelerator and skin care preparation containing the same
JP4839502B2 (en) External preparation for skin containing arginase activity promoter
JP3101090B2 (en) External preparation for skin
JP2001288045A (en) Composition for scalp and hair
JP2004315442A (en) Gray hair-preventing/improving agent
JPH09176030A (en) Medicine for stimulating secretion of sebum
JP5527917B2 (en) Arginase activity promoter and skin external preparation containing the same
JP5711879B2 (en) Fibroblast growth factor-7 production promoter, scalp / hair cosmetic containing the same, and food and drink
JPH08198741A (en) Biological hyarulonic acid synthesis promoter
JP2011126914A (en) Arginase activity accelerator and dermal external medicine containing the same
JP2000178118A (en) Humectant, skin cosmetic and bathing agent
JPS617206A (en) Cell activator
JPH0820521A (en) Keratinizing enzyme activity promoter and cosmetic containing the same

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20070619

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20101005

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20101129

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20101221

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110218

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20110310

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20110310

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20110517

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20131001

R150 Certificate of patent or registration of utility model

Ref document number: 5382969

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term